Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Eslicarbazepine Acetate and Carbamazepine
NCT02284854Phase 1Completed
- Sponsor
- BIAL
- Start
- Jul 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of eslicarbazepine acetate in epilepsy (2 arms), sponsored by BIAL. Primary endpoints: Maximum Plasma Concentration for BIA 2-093, Maximum Plasma Concentration for Carbamazepine and 4 more. Started Jul 2009; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02284854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284854.